166 related articles for article (PubMed ID: 29730433)
41. Expression of Toll-Like Receptors in Peripheral Blood Mononuclear Cells of Patients with Primary Sjögren's Syndrome.
Karlsen M; Jakobsen K; Jonsson R; Hammenfors D; Hansen T; Appel S
Scand J Immunol; 2017 Mar; 85(3):220-226. PubMed ID: 27943374
[TBL] [Abstract][Full Text] [Related]
42. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
[TBL] [Abstract][Full Text] [Related]
43. Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome.
Gestermann N; Koutero M; Belkhir R; Tost J; Mariette X; Miceli-Richard C
Eur Cytokine Netw; 2012; 23(4):166-72. PubMed ID: 23302156
[TBL] [Abstract][Full Text] [Related]
44. Catalpol ameliorates Sjögren's Syndrome by modulating interplay of T and B cells.
Lin R; Hao D; Dong Y; Wang Y
Biomed Pharmacother; 2020 Mar; 123():109806. PubMed ID: 31951976
[TBL] [Abstract][Full Text] [Related]
45. T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome.
Li X; Li X; Qian L; Wang G; Zhang H; Wang X; Chen K; Zhai Z; Li Q; Wang Y; Harris DC
J Rheumatol; 2007 Dec; 34(12):2438-45. PubMed ID: 18050367
[TBL] [Abstract][Full Text] [Related]
46. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
[TBL] [Abstract][Full Text] [Related]
47. Thrombospondin-derived peptide attenuates Sjögren's syndrome-associated ocular surface inflammation in mice.
Contreras Ruiz L; Mir FA; Turpie B; Masli S
Clin Exp Immunol; 2017 Apr; 188(1):86-95. PubMed ID: 28033649
[TBL] [Abstract][Full Text] [Related]
48. A new model of induced experimental systemic lupus erythematosus (SLE) in pigs and its amelioration by treatment with a tolerogenic peptide.
Sharabi A; Dayan M; Zinger H; Mozes E
J Clin Immunol; 2010 Jan; 30(1):34-44. PubMed ID: 19756988
[TBL] [Abstract][Full Text] [Related]
49. miR-146a and miR-155 expression in PBMCs from patients with Sjögren's syndrome.
Shi H; Zheng LY; Zhang P; Yu CQ
J Oral Pathol Med; 2014 Nov; 43(10):792-7. PubMed ID: 24931100
[TBL] [Abstract][Full Text] [Related]
50. Immunoregulatory effects of dental mesenchymal stem cells on T and B lymphocyte responses in primary Sjögren's syndrome.
Genç D; Günaydın B; Sezgin S; Aladağ A; Tarhan EF
Immunotherapy; 2022 Mar; 14(4):225-247. PubMed ID: 35012368
[TBL] [Abstract][Full Text] [Related]
51. Cardamonin inhibits pro-inflammatory cytokine production and suppresses NO pathway in PBMCs from patients with primary Sjögren's syndrome.
Benchabane S; Belguendouz H; Behairi N; Arroul-Lammali A; Boudjelida A; Youinou P; Touil-Boukoffa C
Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):126-133. PubMed ID: 29303022
[TBL] [Abstract][Full Text] [Related]
52. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
[TBL] [Abstract][Full Text] [Related]
53. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood.
Wang Y; Xie X; Zhang C; Su M; Gao S; Wang J; Lu C; Lin Q; Lin J; Matucci-Cerinic M; Furst DE; Zhang G
Ann Rheum Dis; 2022 Mar; 81(3):379-385. PubMed ID: 34462261
[TBL] [Abstract][Full Text] [Related]
54. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
55. Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjögren's syndrome.
Chen W; Yang F; Xu G; Ma J; Lin J
J Leukoc Biol; 2021 Feb; 109(2):437-447. PubMed ID: 33325085
[TBL] [Abstract][Full Text] [Related]
56. Expression of interferon regulatory factor 1, 3, and 7 in primary Sjögren syndrome.
Zheng L; Yu C; Zhang Z; Yang C; Cai X
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):661-8. PubMed ID: 19426920
[TBL] [Abstract][Full Text] [Related]
57. Enhanced expression of NLRP3 inflammasome-related inflammation in peripheral blood mononuclear cells in Sjögren's syndrome.
Kim SK; Choe JY; Lee GH
Clin Chim Acta; 2017 Nov; 474():147-154. PubMed ID: 28965771
[TBL] [Abstract][Full Text] [Related]
58. Effects of calorie restriction on transforming growth factor beta 1 and proinflammatory cytokines in murine Sjogren's syndrome.
Chandrasekar B; McGuff HS; Aufdermorte TB; Troyer DA; Talal N; Fernandes G
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):291-6. PubMed ID: 7554451
[TBL] [Abstract][Full Text] [Related]
59. Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome.
Zilahi E; Tarr T; Papp G; Griger Z; Sipka S; Zeher M
Immunol Lett; 2012 Jan; 141(2):165-8. PubMed ID: 22033216
[TBL] [Abstract][Full Text] [Related]
60. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
